Polaris Electro-Optics
Optical interconnect technology for moving data between AI and data-center systems with lower power consumption.
$50MSeries B
ParticipantMV
M Ventures
m-ventures.com ↗Activity from announced rounds
Activity in this selectionOct 16, 2026 · Jul 19, 2026
M Ventures is Merck KGaA’s strategic venture investor in biotechnology, scientific tools, electronics and frontier technology. Explore its recorded Funding activity.
Investment focus
M Ventures is the strategic corporate venture investor of Merck KGaA, Darmstadt, Germany. Its mandate spans drug development, life-science tools, electronics, frontier technology and sustainability. The team combines financial and strategic objectives and works with founders and co-investors to bring scientific and technical developments toward commercial use.
Activity recorded by RoundOS
RoundOS records activity across both sides of that mandate: drug developers Remepy, TwoStep Therapeutics and TRIMTECH; research-tool businesses Lightcast and Vizgen; and optical-interconnect companies Quintessent and Polaris Electro-Optics. These published financing records describe the activity captured here, rather than the firm’s complete portfolio.
Sources
- Rounds participated in
- 4
- Confirmed lead rounds
- 0 3 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $188.5M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionTwoStep Therapeutics
A peptide-targeting platform is advancing conjugate and radioligand therapies for solid tumors.
$62.5MSeries A
Role not disclosedQuintessent
Makes quantum dot laser chips for AI datacenter optical interconnects
$40MSeries A
Role not disclosedRemepy
Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps
$36MSeries A
Role not disclosed